Dr. Colin Cooke Discusses the Affordable Care Act's Impact on Patient Outcomes
"I think probably most importantly, the Affordable Care Act (ACA) seeks to expand insurance coverage for a large population of people," said Colin Cooke, MD, MSc, Assistant Professor of Medicine, University of Michigan, Ann Arbor, MI. Dr Cooke also discusses the importance of accountable care organizations (ACOs) in regard to the ACA. Groups will be responsible for the cost of care for their patient population as well as the quality of care. Dr Cooke states that the success of accountable care is dependent upon patients no longer being limited to their choice of provider. He says that the quality of care will improve now that there is accountability for measuring quality.
This video was taken on May 19, 2013, at the ATS 2013 International Conference in Philadelphia, PA.
Despite concerns that increasing healthcare coverage for Americans through the Affordable Care Act would lead to substantial strain on the US healthcare delivery system, The Commonwealth Fund found that increases will only modestly increase the demand for healthcare services.
Budget cuts mean county health clinics will be unable to fill hundreds of jobs, leaving smaller staffs to serve low-income people in state that declined to expand Medicaid despite pleas from its hospitals and business leaders.
The American Journal of Managed Care convened a discussion of 2 leading clinicians and 2 medical directors for leading payers, all of whom saw some merit in FDA’s plans to bring oversight to the diagnostic testing market. The strongest advocate for greater FDA oversight was Daniel F. Hayes, MD, clinical director of the Breast Oncology Program at the University of Michigan, who will be a future president of the American Society of Clinical Oncology.
Evidence-Based Oncology, an indexed publication of The American Journal of Managed Care, devotes its current issue to immuno-oncology and the interests of many stakeholders. In a commentary that draws on 30 years of waiting on the promise of immuno-oncology, Bruce Feinberg, DO, outlines the key issues facing payers, oncologists, policymakers and patients themselves.